RSV Vaccine Guillain-Barré Syndrome Side Effects To Be Added to Warning Labels for Abrysvo and Arexvy
Some recipients of the RSV vaccines developed Guillain-Barré syndrome within 42 days of receiving the injection, according to FDA warning.
January 08, 2025 By: Martha Garcia
Some recipients of the RSV vaccines developed Guillain-Barré syndrome within 42 days of receiving the injection, according to FDA warning.
A lawsuit filed by six women claim the recalled BioZorb implant was defectively designed, causing pain, infections, swelling and fears of a return of their breast cancer.
A federal judge has ordered plaintiffs and defendants involved in hair relaxer cancer litigation to select 20 cases each, for a total of 40, to undergo case-specific discovery to prepare them to serve as potential bellwether trials.
A federal judge has approved the direct filing of AngioDynamics port catheter lawsuits in the U.S. District Court for the District of Southern California, where the litigation has been centralized for coordinated discovery and pretrial proceedings.
"*" indicates required fields